Home LiteratureArticle Details
PMID: 7035868 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Molecular and cellular biochemistry ·Vol. 41 ·1981-12-04 ·Pages 27-47

Adam A, Petit JF, Lefrancier P, Lederer E

Abstract

暂无摘要

MeSH Terms
Acetylmuramyl-Alanyl-Isoglutamine/analogs & derivatives,immunology,metabolism Animals Antibody Formation Autoantibodies/immunology Bacterial Infections/prevention & control Fever/chemically induced Freund's Adjuvant/analysis Glycopeptides/metabolism Immunity, Cellular/drug effects Immunization Mitosis/drug effects Models, Chemical Neoplasms/immunology Polymers Stereoisomerism
Chemicals
Autoantibodies Glycopeptides Polymers Acetylmuramyl-Alanyl-Isoglutamine Freund's Adjuvant
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Adam A
Petit J F
Lefrancier P
Lederer E
References (130)
130 references, click to expand
  1. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.
    Infect Immun. 1980 Jun;28(3):881-6 PMID: 6995325
  2. Separation of a water-soluble adjuvant (MAF3) from delipidated cells of Mycobacterium tuberculosis strain Aoyama B by hydrogenolysis and gel filtration.
    Jpn J Microbiol. 1976 Jun;20(3):183-90 PMID: 823353
  3. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine.
    Gan. 1976 Dec;67(6):867-77 PMID: 828599
  4. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
    J Infect Dis. 1978 Dec;138(6):760-7 PMID: 368262
  5. Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes.
    Cell Immunol. 1978 Jul;38(2):286-93 PMID: 567100
  6. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.
    Infect Immun. 1979 Apr;24(1):83-9 PMID: 313372
  7. A guinea pig model for tumor immunology. A summary.
    Isr J Med Sci. 1973 Mar;9(3):366-74 PMID: 4122812
  8. Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.
    Infect Immun. 1976 Jul;14(1):18-27 PMID: 820642
  9. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
    Prog Allergy. 1978;25:63-105 PMID: 362430
  10. Synthesis of N-acetyl-6-amino- and -6-(acylamino)-6-deoxymuramoyl dipeptides, and their immunoadjuvant activities.
    Carbohydr Res. 1980 Feb;79(1):C20-3 PMID: 7357567
  11. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
    J Infect Dis. 1980 Nov;142(5):708-15 PMID: 7462686
  12. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
    Immunology. 1980 Mar;39(3):441-50 PMID: 6160092
  13. Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue.
    Biochem Biophys Res Commun. 1980 Sep 30;96(2):915-23 PMID: 7426019
  14. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
    Cell Immunol. 1979 Mar 1;43(1):137-49 PMID: 313841
  15. Central pyrogenic activity of muramyl dipeptide.
    J Exp Med. 1980 Oct 1;152(4):869-77 PMID: 7420023
  16. Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers.
    Biochem Biophys Res Commun. 1976 Sep 7;72(1):339-46 PMID: 985477
  17. Potentiation of the immune response to influenza virus subunit vaccines.
    J Immunol. 1977 Dec;119(6):2073-7 PMID: 915292
  18. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Immunology. 1978 Dec;35(6):963-70 PMID: 738768
  19. Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria.
    Biken J. 1975 Jun;18(2):77-92 PMID: 1180872
  20. Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide.
    Infect Immun. 1979 Jul;25(1):273-8 PMID: 113344
  21. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
    Ann Immunol (Paris). 1977 Apr-Jun;128C(3):653-61 PMID: 869513
  22. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs.
    Microbiol Immunol. 1979;23(8):821-3 PMID: 120487
  23. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Biochem Biophys Res Commun. 1978 Nov 29;85(2):684-90 PMID: 367370
  24. Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis.
    Cell Immunol. 1978 Jan;35(1):158-67 PMID: 74289
  25. Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.
    Int J Immunopharmacol. 1979;1(1):35-41 PMID: 551094
  26. [Autoimmune aspermatogenetic orchiepididymitis in guinea pigs induced by water-soluble adjuvants].
    Ann Immunol (Paris). 1977 Jan-Mar;128(1-2):267-9 PMID: 557950
  27. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Z Immunitatsforsch Immunobiol. 1978 Oct;155(1):87-92 PMID: 706536
  28. The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro.
    Int J Immunopharmacol. 1979;1(1):17-27 PMID: 95186
  29. Macrophage activation by bacterial cell walls and related synthetic compounds.
    Infect Immun. 1979 Jul;25(1):48-53 PMID: 478648
  30. Immunotherapy with an intralesionally administered synthetic cord factor analogue.
    Int J Cancer. 1978 Nov 15;22(5):564-9 PMID: 721317
  31. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
    J Reticuloendothel Soc. 1979 Dec;26(Suppl):631-41 PMID: 392087
  32. One non-specific signal triggers b lymphocytes.
    Transplant Rev. 1975;23:126-37 PMID: 1094629
  33. [Adjuvant activity of peptidoglyoans from mycobacteria].
    C R Acad Sci Hebd Seances Acad Sci D. 1974 Feb 4;278(6):799-801 PMID: 4211289
  34. The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT.
    Immunology. 1975 Jul;29(1):1-15 PMID: 806515
  35. Structural specificity of synthetic peptide adjuvant for induction of experimental allergic encephalomyelitis.
    Cell Immunol. 1978 Jan;35(1):168-72 PMID: 620426
  36. Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.
    Infect Immun. 1979 May;24(2):313-8 PMID: 457277
  37. FEBS Lett. 1969 Jul;4(2):87-92 PMID: 11947153
  38. In vitro responsiveness of immunocytes to a synthetic immunoadjuvant, muramyl dipeptide, and different synthetic analogs.
    Antibiot Chemother (1971). 1978;24:19-29 PMID: 655676
  39. Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca.
    Infect Immun. 1973 Jun;7(6):855-61 PMID: 4716544
  40. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.
    Proc Natl Acad Sci U S A. 1979 Dec;76(12):6557-61 PMID: 293743
  41. [Adjuvant activity of Gram-negative bacterial peptidoglycans in delayed hypersensitivity].
    C R Acad Sci Hebd Seances Acad Sci D. 1973 Jun 25;276(26):3499-500 PMID: 4199082
  42. [Increase in the non-specific resistance to infection in mice after oral administration of 2 synthetic glycopeptides with adjuvant activity].
    C R Acad Sci Hebd Seances Acad Sci D. 1977 Jan 31;284(5):405-8 PMID: 404070
  43. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
    Infect Immun. 1978 Jun;20(3):600-7 PMID: 97234
  44. Nor-MDP, saponin, corynebacteria, and pertussis organisms as immunological adjuvants in experimental malaria vaccination of macaques.
    Bull World Health Organ. 1979;57 Suppl 1:189-97 PMID: 232428
  45. Peptidoglycan adjuvants: minimal structure required for activity.
    Z Immunitatsforsch Exp Klin Immunol. 1975 Jul;149(2-4):341-8 PMID: 126566
  46. Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.
    Proc Natl Acad Sci U S A. 1975 Oct;72(10):4105-9 PMID: 812088
  47. Correlation of stereochemically specific structure in muramyl dipeptide between macrophage activation and adjuvant activity.
    Biochem Biophys Res Commun. 1977 Jul 25;77(2):621-7 PMID: 901491
  48. Modulation of myelopoiesis by different bacterial cell-wall components: induction of colony-stimulating activity (by pure preparations, low-molecular-weight degradation products, and a synthetic low-molecular analog of bacterial cell-wall components) in vitro.
    Cell Immunol. 1978 Apr;37(1):174-87 PMID: 306883
  49. The mode of action of immunologic adjuvants.
    Bibl Tuberc. 1956;(10):130-48 PMID: 13341884
  50. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Microbiol Immunol. 1979;23(9):933-6 PMID: 576117
  51. [Effect of muramyldipeptide (MDP) on rat resistance to Schistosoma mansoni].
    C R Seances Soc Biol Fil. 1980;173(6):1046-9 PMID: 6446355
  52. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    J Immunol. 1980 Jan;124(1):320-5 PMID: 6985643
  53. A human T-independent B lymphocyte mitogen extracted from Nocardia opaca.
    J Immunol. 1976 Nov;117(5 Pt 1):1434-9 PMID: 1087313
  54. Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response.
    Eur J Immunol. 1974 May;4(5):352-6 PMID: 4604064
  55. [Enhancement of the immune response to influenza vaccine by a synthetic glycopeptide adjuvant (N-acetyl muramy1-L-analyl-D-isoglutamine)].
    C R Acad Sci Hebd Seances Acad Sci D. 1977 Sep 12;285(4):467-70 PMID: 410526
  56. Synthetic immunostimulants derived from the bacterial cell wall.
    J Med Chem. 1980 Aug;23(8):819-25 PMID: 6995612
  57. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.
    J Immunol. 1979 Jun;122(6):2226-31 PMID: 221582
  58. Adjuvant activities in production of reaginic antibody in mice of bacterial cell wall peptidoglycans or peptidoglycan subunits and of synthetic N-acetylmuramyl dipeptides.
    Biken J. 1977 Dec;20(3-4):131-6 PMID: 614855
  59. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    J Natl Cancer Inst. 1974 May;52(5):1571-7 PMID: 4364736
  60. Regulation of antibody response in different immunoglobulin classes. VI. Selective suppression of IgE response by administration of antigen-conjugated muramylpeptides.
    J Immunol. 1979 Dec;123(6):2709-15 PMID: 315431
  61. Adjuvant activity of monomeric bacterial cell wall peptidoglycans.
    Biochem Biophys Res Commun. 1974 Feb 4;56(3):561-7 PMID: 4597063
  62. Structure specificity of some immunoadjuvant synthetic glycopeptides.
    Experientia. 1979 Oct 15;35(10):1397-8 PMID: 499439
  63. Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: factors affecting the response.
    Cell Immunol. 1979 Feb;42(2):336-43 PMID: 371818
  64. Enhancement by muramyl dipeptide of in vitro nude mice responses to a T-dependent antigen.
    Immunol Commun. 1979;8(1):55-64 PMID: 311334
  65. Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.
    Nat New Biol. 1972 Aug 23;238(86):241-2 PMID: 4562114
  66. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.
    Biken J. 1977 Jun;20(2):39-45 PMID: 588232
  67. Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.
    J Exp Med. 1980 Jan 1;151(1):101-14 PMID: 7350246
  68. Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide.
    Eur J Immunol. 1980 Aug;10(8):647-53 PMID: 6772453
  69. Synthesis of conjugates containing N-acetylmuramyl-L-alanyl-D-isoglutaminyl (MDP). Their use as hapten-carrier systems.
    Mol Immunol. 1980 Mar;17(3):357-63 PMID: 7442679
  70. Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures.
    J Immunol. 1978 Jul;121(1):383-9 PMID: 307582
  71. Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives.
    Biochem Biophys Res Commun. 1975 Oct 27;66(4):1316-22 PMID: 1191296
  72. Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.
    Infect Immun. 1978 Mar;19(3):966-71 PMID: 346491
  73. Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs.
    Carbohydr Res. 1980 Feb;79(1):C17-9 PMID: 7357566
  74. Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.
    Cell Immunol. 1977 Mar 1;29(1):195-9 PMID: 321136
  75. Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs.
    Jpn J Microbiol. 1976 Feb;20(1):63-6 PMID: 1271589
  76. Presence and subcellular localization of two distinct mitogenic fractions in the cells of Nocardia rubra and Nocardia opaca: preparation of soluble mitogenic peptidoglycan fractions.
    Infect Immun. 1976 Apr;13(4):1084-90 PMID: 1278999
  77. [Interferon induced in the hamster by subunits of "Nocardia": essay of protection against rabies (author's transl)].
    Ann Microbiol (Paris). 1979 Aug-Sep;130B(2):263-9 PMID: 43690
  78. Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats.
    Infect Immun. 1979 Nov;26(2):690-7 PMID: 546792
  79. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Eur J Immunol. 1978 Aug;8(8):558-62 PMID: 359336
  80. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Infect Immun. 1980 Mar;27(3):826-31 PMID: 7380554
  81. [Adjuvant activity of monomeric fractions of bacterial peptidoglycans in delayed hypersensitivity].
    C R Acad Sci Hebd Seances Acad Sci D. 1974 Dec 17;277(24):2841-4 PMID: 4211288
  82. Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae.
    Infect Immun. 1975 Feb;11(2):257-64 PMID: 1089598
  83. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.
    Biken J. 1977 Dec;20(3-4):95-103 PMID: 614856
  84. Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate.
    Science. 1980 Apr 25;208(4442):415-6 PMID: 7189295
  85. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.
    Cell Immunol. 1979 Dec;48(2):369-74 PMID: 228871
  86. Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.
    Proc Natl Acad Sci U S A. 1972 Apr;69(4):851-4 PMID: 4502937
  87. Stimulation of an enhanced in vitro immune response by a synthetic adjuvant, muramyl dipeptide.
    J Immunol. 1978 Feb;120(2):487-91 PMID: 413867
  88. Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs.
    Int J Pept Protein Res. 1977;9(4):249-57 PMID: 852928
  89. Inhibition of macrophage migration by synthetic muramyl dipeptide.
    Biochem Biophys Res Commun. 1978 Feb 28;80(4):923-8 PMID: 637877
  90. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Eur J Immunol. 1980 Aug;10(8):654-6 PMID: 6995138
  91. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    J Immunol. 1978 Oct;121(4):1219-22 PMID: 701793
  92. [Immunostimulating and adjuvant activities of a low molecular weight lipopeptide].
    C R Seances Acad Sci D. 1979 Sep 24;289(5):473-6 PMID: 117939
  93. Effects of chemical modifications of the glutamic acid residue in N-acetylmuramyl peptides on the immunoadjuvancies of the molecules.
    Biken J. 1977 Dec;20(3-4):125-30 PMID: 614854
  94. The role of mycobacteria and silica in the immunological response of the guinea-pig.
    Immunology. 1966 Sep;11(3):229-41 PMID: 4162436
  95. Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.
    Infect Immun. 1977 Jan;15(1):332-4 PMID: 832904
  96. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.
    Proc Natl Acad Sci U S A. 1977 May;74(5):2089-93 PMID: 325566
  97. Immunological activity of the peptidoglycan.
    Z Immunitatsforsch Exp Klin Immunol. 1975 Jul;149(2-4):136-50 PMID: 52236
  98. Muramyl dipeptide-induced adjuvant arthritis.
    Infect Immun. 1980 May;28(2):624-6 PMID: 7399679
  99. Adjuvant and antitumor activities of quinonyl-N-acetylmuramyldipeptides.
    Gan. 1979 Dec;70(6):847-8 PMID: 535688
  100. Enhancement of carrier-specific helper T cell function by the synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    J Immunol. 1978 Mar;120(3):980-2 PMID: 344799
  101. Failure of synthetic muramyl dipeptide to increase antibacterial resistance.
    Infect Immun. 1980 Feb;27(2):288-91 PMID: 6155329
  102. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Cell Immunol. 1979 Jun;45(1):199-206 PMID: 313275
  103. In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.
    Cell Immunol. 1978 Jan;35(1):173-9 PMID: 563773
  104. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.
    Infect Immun. 1981 Apr;32(1):273-6 PMID: 7216489
  105. Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.
    Biken J. 1976 Mar;19(1):9-13 PMID: 779765
  106. Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs.
    Infect Immun. 1979 Aug;25(2):645-52 PMID: 314932
  107. Modulation of the immune response by a synthetic adjuvant and analogs.
    Proc Natl Acad Sci U S A. 1976 Jul;73(7):2472-5 PMID: 1065901
  108. On the mechanism of early recovery of specifically depleted lymphoid cell populations by nonspecific activation of T cells.
    Cell Immunol. 1978 Apr;37(1):151-61 PMID: 306882
  109. Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey.
    Biochim Biophys Acta. 1970 Jun;208(3):444-51 PMID: 4990198
  110. Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes.
    Proc Soc Exp Biol Med. 1977 Jul;155(3):349-52 PMID: 877134
  111. Inabilities as an immunoadjuvant of cell walls of the group B peptidoglycan types and those of arthrobacters.
    Biken J. 1977 Mar;20(1):1-4 PMID: 880204
  112. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    J Immunol. 1980 Jan;124(1):100-4 PMID: 6965289
  113. Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.
    Cell Immunol. 1976 Feb;21(2):243-9 PMID: 1260863
  114. [Effects of mycobacterial hydrosoluble adjuvants on the induction and prevention of experimental autoimmune uveo-retinitis in guinea-pigs (author's transl)].
    Ann Immunol (Paris). 1979 Jan-Feb;130C(1):29-32 PMID: 434782
  115. Induction of interferon synthesis in mice by fractions from Nocardia.
    Infect Immun. 1978 Feb;19(2):353-6 PMID: 75845
  116. Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant.
    Science. 1978 Sep 29;201(4362):1237-9 PMID: 99814
  117. Immunotherapy with nonviable microbial components.
    Ann N Y Acad Sci. 1976;277(00):228-38 PMID: 187099
  118. Chemical structure required for immunoadjuvant and arthritogenic activities of cell wall peptidoglycans.
    Mol Immunol. 1979 Mar;16(3):153-62 PMID: 489051
  119. The metabolic fate of 14C-labeled peptidoglycan monomer in mice. I. Identification of the monomer and the corresponding pentapeptide in urine.
    Biochim Biophys Acta. 1980 Apr 17;629(1):77-82 PMID: 7370309
  120. Induction of antibody-forming cell clones in microcultures.
    Eur J Immunol. 1972 Aug;2(4):360-6 PMID: 4563349
  121. Lipophilic derivative of muramyl dipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion.
    Infect Immun. 1980 Aug;29(2):617-22 PMID: 6260655
  122. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    J Infect Dis. 1978 Sep;138(3):378-86 PMID: 100563
  123. Immunization against malaria with antigen from Plasmodium falciparum cultivated in vitro.
    Proc Natl Acad Sci U S A. 1978 Nov;75(11):5665-8 PMID: 103100
  124. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.
    Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317-25 PMID: 4606813
  125. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
    Proc Natl Acad Sci U S A. 1978 Jul;75(7):3395-9 PMID: 356054
  126. Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.
    Mol Cell Biochem. 1975 May 30;7(2):87-104 PMID: 1095912
  127. Adjuvanticity of mycobacterial cell walls.
    Jpn J Microbiol. 1971 Mar;15(2):193-7 PMID: 4930810
  128. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
    Biken J. 1975 Jun;18(2):105-11 PMID: 1180867
  129. The influence of components of M. tuberculosis and other Mycobacteria upon antibody production to ovalbumin.
    Immunology. 1958 Jan;1(1):54-66 PMID: 13513142
  130. Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor.
    Cell Immunol. 1980 Mar 1;50(1):71-81 PMID: 6967358
Article Info
Journal
Molecular and cellular biochemistry
Abbr.
Mol Cell Biochem
ISSN
0300-8177
DOI
10.1007/BF00225295
Published
1981-12-04
Pages
27-47
Language
English
Region
Netherlands
NLM ID
0364456
Subset
IM
External Links
PubMed source DOI: 10.1007/BF00225295 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2